Ondansetron: A Novel Treatment to Reduce the Severity of Neonatal Opioid Withdrawal Syndrome?

A transition from a pharmacological-based model of care, such as Finnegan scoring, to a behavioral-based model, such as the Eat-Sleep-Console, for newborns experiencing neonatal abstinence syndrome (NAS) or neonatal opioid withdrawal syndrome (NOWS)…

Preview only. Read the full abstract at the source